Counterfeit clippings: news in brief
The Pharmaceutical Research and Manufacturers of America (PhRMA) has been denied involvement in an ongoing lawsuit in Maine, US, which is trying to repeal a law that allows state residents to buy medicines from other countries such as Canada, reports Pharmalot. The drug industry organisation has been using the lawsuit as a platform to warn of the dangers of allowing people to import drugs from overseas, which it maintains raises the risk of exposure to falsified, expired or low quality medicines. The judge in the case has concluded however that PhRMA should be shut out from proceedings because it was unable to demonstrate how drugmakers could be harmed by the law. Responding to its exclusion, PhRMA associate general counsel John Murphy said the organisation “continues to believe that Maine’s drug importation law conflicts with FDA’s authority to regulate prescription medication distribution in the US.”
Related Posts
Anti-counterfeit technology news in brief
Norway's Thinfilm Electronics' near-field communications (NFC) tags have joined...
Big tobacco eyes Myanmar market
As the country opens up to foreign multinationals, tobacco giants are staking a...
Assam police seize fake currency notes worth Rs 60.58 lakh, 1 person held
Assam police on Saturday recovered and seized fake Indian currency notes of Rs...
Greek crisis and tax hike foster cigarette smuggling
(ANSAmed) - Naples - Consumption of smuggled cigarettes has risen by about 50% in...